TAK-802

• Description :

  TAK-802 is an orally active and potent acetylcholinesterase inhibitor. TAK-802’s distribution in red blood cells has a significant concentration dependence, with the distribution ratio decreasing as the concentration increases. TAK-802 exhibits significant nonlinear pharmacokinetic behavior[1].

• UNSPSC :

  12352005

• Target :

  Cholinesterase (ChE)

• Related Pathways :

  Neuronal Signaling

• Field of Research :

  Neurological Disease

• Smiles :

  O=C1N2C3=C(C=C(C(CCC4CCN(CC5=CC=CC(F)=C5)CC4)=O)C=C3CC2)CC1

• Molecular Formula :

  C26H29FN2O2

• Molecular Weight :

  420.52

• References & Citations :

  [1]Kakehi M, et al. The effects of the concentration-dependent erythrocyte distribution of TAK-802, a potent acetylcholinesterase inhibitor, on rat pharmacokinetics. Biopharm Drug Dispos. 2016 Nov;37 (8) :467-478.

• Shipping Conditions :

  Room temperature

• Scientific Category :

  Reference compound1

• Clinical Information :

  Phase 2

• CAS Number :

  [263248-16-4]